<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1646-2122</journal-id>
<journal-title><![CDATA[Revista Portuguesa de Ortopedia e Traumatologia]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Port. Ortop. Traum.]]></abbrev-journal-title>
<issn>1646-2122</issn>
<publisher>
<publisher-name><![CDATA[Sociedade Portuguesa de Ortopedia e Traumatologia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1646-21222012000400005</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Factores de risco para a infecção em artroplastia total do joelho]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodrigues]]></surname>
<given-names><![CDATA[Pedro]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[Manuel]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Antunes]]></surname>
<given-names><![CDATA[Artur]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Neves]]></surname>
<given-names><![CDATA[Nuno]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[Paulo]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[Rui]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
<xref ref-type="aff" rid="A02"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Centro Hospitalar São João Serviço de Ortopedia e Traumatologia ]]></institution>
<addr-line><![CDATA[Porto ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Universidade do Porto Faculdade de Medicina ]]></institution>
<addr-line><![CDATA[Porto ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2012</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2012</year>
</pub-date>
<volume>20</volume>
<numero>4</numero>
<fpage>437</fpage>
<lpage>443</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S1646-21222012000400005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S1646-21222012000400005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S1646-21222012000400005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Objectivo: Identificar os factores de risco que podem prever maior probabilidade de infecção após artroplastia total do joelho, de forma a estratificar o risco relativo, com vista à adopção de estratégias de prevenção. Materiais e métodos: estudo retrospectivo, comparativo, entre pacientes infectados e não infectados, consecutivamente submetidos a artroplastia primária total do joelho, operados entre Janeiro de 2008 e Setembro de 2009. Os factores avaliados foram: duração do internamento, duração da cirurgia, antibiótico utilizado na proxilaxia e o tempo de administração, volume de perdas hemáticas, volume de transfusão de glóbulos rubros, o tipo de anestesia, e ainda no que respeita às comorbilidades, a classificação ASA, presença de hipertensão arterial, Diabetes Mellitus, obesidade (IMC&gt;30) e imunodepressão. Resultados foram avaliados 239 doentes com um seguimento médio de 20 meses. Identificámos 10 infecções profundas (4,18%), e 10 superficiais. Foi encontrada correlação positiva entre infecção e obesidade (p<0,01), imunodepressão (p<0,01), e número de unidades de GR transfundidos (p=0,02). Conclusão: a incidência de infecção pós artroplastia total do joelho em pacientes consecutivamente operados num hospital central foi elevada. A obesidade, a imunodepressão e o volume transfusional administrado foram factores de risco significativos para a ocorrência de infecção. Outros factores, habitualmente referidos na literatura, não mostraram associação ou a tendência para infecção não atingiu significado estatístico. A identificação e modificação dos factores de risco implicados adivinham-se fulcrais na redução e prevenção de infecção em artroplastia.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Objectives: Determine the evidence based probability of the involved risk factors in predisposing infection following total knee arthroplasty. Methods: Retrospective comparison between infected and uninfected patients, consecutively undergoing primary total knee arthroplasty, operated between January 2008 and September 2009. The factors evaluated were: duration of hospitalization, duration of surgery, prophylactic antibiotics and timing of administration, volume of blood loss, volume of blood transfusion, anesthetic technique, and also possible host risk factors, the ASA classification, high blood pressure, Diabetes Mellitus, Obesity (BMI&gt;30) and immunosuppression. Results: We evaluated 239 patients with a mean follow-up of 20 months. We identified 10 deep infections (4.18%), and 10 superficial wound infections and found a positive correlation between infection and obesity (p <0.01), immunosuppression (p <0.01), and volume of blood transfusion (p=0.02). Conclusion: The incidence of infection after total knee arthroplasty in patients consecutively operated in a tertiary referral hospital was high. The presence of obesity, immunosuppression and the volume of blood transfusion administered were identified as significant risk factors for infection to occur. Other factors, commonly referred to in the literature, showed no association, or the tendency for infection did not reach statistical significance. The identification, modification or eviction of the risk factors implied are essential to reduce and prevent infection in arthroplasty.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Artroplastia]]></kwd>
<kwd lng="pt"><![CDATA[joelho]]></kwd>
<kwd lng="pt"><![CDATA[infecção]]></kwd>
<kwd lng="pt"><![CDATA[prevenção]]></kwd>
<kwd lng="en"><![CDATA[Arthroplasty]]></kwd>
<kwd lng="en"><![CDATA[knee]]></kwd>
<kwd lng="en"><![CDATA[infection]]></kwd>
<kwd lng="en"><![CDATA[prevention]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><b><font face="Verdana" size="2">ARTIGO ORIGINAL</font></b></p>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="4">Factores de risco para a infecção em artroplastia total do joelho</font></b></p>    <p>&nbsp;</p>    <p><font face="Verdana" size="2"><b>Pedro Rodrigues<sup>I, II</sup></b>; <b>Manuel Silva<sup>I, II</sup></b>; <b>Artur Antunes<sup>I, II</sup></b>; <b>Nuno Neves<sup>I, II</sup></b>; <b>Paulo Oliveira<sup>I, II</sup></b>; <b>Rui Pinto<sup>I, II</sup></b></font></p>    <p><font face="Verdana" size="2">I. Serviço de Ortopedia e Traumatologia. Centro Hospitalar São João. Porto. Portugal.<br />II. Faculdade de Medicina da Universidade do Porto. Porto. Portugal.<br /></font></p>    <p>&nbsp;</p>    <p><font face="Verdana" size="2"><a name="topc"></a><a href="#c">Endereço para correspondência</a></font></p>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="2">RESUMO</font></b></p><font face="verdana" size="2">    ]]></body>
<body><![CDATA[<p>Objectivo: Identificar os factores de risco que podem prever maior probabilidade de infec&ccedil;&atilde;o ap&oacute;s artroplastia total do joelho, de forma a estratificar o risco relativo, com vista &agrave; adop&ccedil;&atilde;o de estrat&eacute;gias de preven&ccedil;&atilde;o.</p>     <p>Materiais e m&eacute;todos: estudo retrospectivo, comparativo, entre pacientes infectados e n&atilde;o infectados, consecutivamente submetidos a artroplastia prim&aacute;ria total do joelho, operados entre Janeiro de 2008 e Setembro de 2009. Os factores avaliados foram: dura&ccedil;&atilde;o do internamento, dura&ccedil;&atilde;o da cirurgia, antibi&oacute;tico utilizado na proxilaxia e o tempo de administra&ccedil;&atilde;o, volume de perdas hem&aacute;ticas, volume de transfus&atilde;o de gl&oacute;bulos rubros, o tipo de anestesia, e ainda no que respeita &agrave;s comorbilidades, a classifica&ccedil;&atilde;o ASA, presen&ccedil;a de hipertens&atilde;o arterial, Diabetes Mellitus, obesidade (IMC&gt;30) e imunodepress&atilde;o.</p>     <p>Resultados foram avaliados 239 doentes com um seguimento m&eacute;dio de 20 meses. Identific&aacute;mos 10 infec&ccedil;&otilde;es profundas (4,18%), e 10 superficiais. Foi encontrada correla&ccedil;&atilde;o positiva entre infec&ccedil;&atilde;o e obesidade (p&lt;0,01), imunodepress&atilde;o (p&lt;0,01), e n&uacute;mero de unidades de GR transfundidos (p=0,02).</p>     <p>Conclus&atilde;o: a incid&ecirc;ncia de infec&ccedil;&atilde;o p&oacute;s artroplastia total do joelho em pacientes consecutivamente operados num hospital central foi elevada.</p>     <p>A obesidade, a imunodepress&atilde;o e o volume transfusional administrado foram factores de risco significativos para a ocorr&ecirc;ncia de infec&ccedil;&atilde;o. Outros factores, habitualmente referidos na literatura, n&atilde;o mostraram associa&ccedil;&atilde;o ou a tend&ecirc;ncia para infec&ccedil;&atilde;o n&atilde;o atingiu significado estat&iacute;stico.</p>     <p>A identifica&ccedil;&atilde;o e modifica&ccedil;&atilde;o dos factores de risco implicados adivinham-se fulcrais na redu&ccedil;&atilde;o e preven&ccedil;&atilde;o de infec&ccedil;&atilde;o em artroplastia.</p></font>    <p><font face="verdana" size="2"><b>Palavras chave</b>: Artroplastia, joelho, infecção, prevenção. </font></p>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="2">ABSTRACT</font></b></p><font face="verdana" size="2">    <p>Objectives: Determine the evidence based probability of the involved risk factors in predisposing infection following total knee arthroplasty.</p>     ]]></body>
<body><![CDATA[<p>Methods: Retrospective comparison between infected and uninfected patients, consecutively undergoing primary total knee arthroplasty, operated between January 2008 and September 2009. The factors evaluated were: duration of hospitalization, duration of surgery, prophylactic antibiotics and timing of administration, volume of blood loss, volume of blood transfusion, anesthetic technique, and also possible host risk factors, the ASA classification, high blood pressure, Diabetes Mellitus, Obesity (BMI&gt;30) and immunosuppression.</p>     <p>Results: We evaluated 239 patients with a mean follow-up of 20 months. We identified 10 deep infections (4.18%), and 10 superficial wound infections and found a positive correlation between infection and obesity (p &lt;0.01), immunosuppression (p &lt;0.01), and volume of blood transfusion (p=0.02).</p>     <p>Conclusion: The incidence of infection after total knee arthroplasty in patients consecutively operated in a tertiary referral hospital was high.</p>     <p>The presence of obesity, immunosuppression and the volume of blood transfusion administered were identified as significant risk factors for infection to occur. Other factors, commonly referred to in the literature, showed no association, or the tendency for infection did not reach statistical significance.</p>     <p>The identification, modification or eviction of the risk factors implied are essential to reduce and prevent infection in arthroplasty.</p></font>    <p><font face="verdana" size="2"><b>Key words</b>: Arthroplasty, knee, infection, prevention. </font></p>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="2">INTRODUÇÃO</font></b></p><font face="verdana" size="2">    <p>A infec&ccedil;&atilde;o &eacute; a complica&ccedil;&atilde;o mais temida pelos cirurgi&otilde;es e apresenta-se como um dos maiores desafios na cirurgia de artroplastia[1]. A infec&ccedil;&atilde;o assume-se como a segunda maior complica&ccedil;&atilde;o p&oacute;s artroplastia total prim&aacute;ria do joelho (ATJ), apenas ultrapassada pelo descolamento ass&eacute;ptico[<sup>2,3</sup>], ocorrendo em 1-4% das ATJ[<sup>4,5</sup>] e pode atingir uma taxa de mortalidade de 2,7-18%[<sup>6,7</sup>].</p>
    <p><em>Kurtz et al.</em> num estudo recente prev&ecirc;em que o n&uacute;mero de artroplastias totais do joelho realizado anualmente ascender&aacute; de 450 mil em 2005 para 3,48 milh&otilde;es em 2030, o que traduz um aumento relativo de 673% que representa 70 000 doentes com infec&ccedil;&atilde;o de artroplastia por ano[8]. Haver&aacute; igualmente um aumento proporcional da popula&ccedil;&atilde;o em risco de infec&ccedil;&atilde;o[<sup>8,9</sup>].</p>
    ]]></body>
<body><![CDATA[<p>Tendo em considera&ccedil;&atilde;o que um epis&oacute;dio de infec&ccedil;&atilde;o periprot&eacute;sica acarreta um custo estimado 3-4 vezes superior ao da artroplastia prim&aacute;ria, estimam-se encargos psicosocioecon&oacute;micos devastadores, tanto para o paciente como para o sistema de sa&uacute;de respons&aacute;vel[9].</p>
    <p>O objectivo deste trabalho &eacute; identificar os factores de risco que podem prever maior probabilidade de infec&ccedil;&atilde;o e desta forma estratificar o risco relativo, seleccionar os pacientes de alto risco, e adoptar estrat&eacute;gias de preven&ccedil;&atilde;o m&aacute;ximas.</p></font>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="2">MATERIAL E MÉTODOS</font></b></p><font face="verdana" size="2">    <p>Estudo retrospectivo, comparativo, entre pacientes infectados e n&atilde;o infectados consecutivamente submetidos a artroplastia prim&aacute;ria total do joelho por gonartrose tricompartimental, operados entre Janeiro de 2008 e Setembro de 2009.</p>
    <p>Pela consulta dos processos cl&iacute;nicos foram registados factores extr&iacute;nsecos ao doente: dura&ccedil;&atilde;o de cirurgia, antibi&oacute;tico profil&aacute;ctico (cefazolina vs teicoplanina) e <em>timing</em> de administra&ccedil;&atilde;o (&lt;30min vs &gt;30 min), tipo de anestesia utilizado (geral vs neuroeixo), perdas hem&aacute;ticas e volume transfusional; e factores intr&iacute;nsecos: classifica&ccedil;&atilde;o ASA, e a presen&ccedil;a de comorbilidades como hipertens&atilde;o arterial, diabetes mellitus, obesidade (&Iacute;ndice de massa corporal - IMC &gt; 30) e imunodepress&atilde;o (doen&ccedil;as inflamat&oacute;rias cr&oacute;nicas com corticoterapia ou imunossupressores ou insufici&ecirc;ncia renal ou hep&aacute;tica cr&oacute;nicas).</p>
    <p>A t&eacute;cnica peroperat&oacute;ria consistiu na lavagem mec&acirc;nica do membro inferior com iodopovidona e administra&ccedil;&atilde;o de antibi&oacute;tico profil&aacute;ctico previamente &agrave; insufla&ccedil;&atilde;o de garrote pneum&aacute;tico na raiz da coxa. Procedeu-se a artroplastia cimentada e coloca&ccedil;&atilde;o de dreno aspirativo.<ins cite="mailto:Pedro" datetime="2012-01-16T00:10"></ins></p>
    <p>Foram adoptadas as defini&ccedil;&otilde;es do <em>Center for Disease Control</em> para infec&ccedil;&otilde;es[10]. Assim, infec&ccedil;&atilde;o superficial foi definida como aquela que ocorre nos primeiros 30 dias ap&oacute;s a opera&ccedil;&atilde;o, envolvendo a pele e tecido celular subcut&acirc;neo da incis&atilde;o, e com, pelo menos uma das seguintes: drenagem purulenta com ou sem confirma&ccedil;&atilde;o laboratorial, isolamento do microorganismo, sinais inflamat&oacute;rios locais ou diagn&oacute;stico de infec&ccedil;&atilde;o superficial feito pelo cirurgi&atilde;o. A infec&ccedil;&atilde;o profunda &eacute; definida como ocorrendo no primeiro ano ap&oacute;s a cirurgia envolvendo os tecidos profundos e com, pelo menos, uma das seguintes: drenagem purulenta, deisc&ecirc;ncia espont&acirc;nea ou abertura deliberada pelo cirurgi&atilde;o na presen&ccedil;a de sinais inflamat&oacute;rios (febre e dor local), abcesso ou outra evid&ecirc;ncia de infec&ccedil;&atilde;o dos tecidos profundos em exame directo, reopera&ccedil;&atilde;o, exame histopatol&oacute;gico ou radiol&oacute;gico, ou diagn&oacute;stico de infec&ccedil;&atilde;o profunda feito pelo cirurgi&atilde;o.</p>
    <p>An&aacute;lise estat&iacute;stica com SPSS Statistics 17.0 (<em>teste exacto de Fisher</em>, <em>teste de Mann-Whitney e student t-test</em>). Signific&acirc;ncia estat&iacute;stica para p&le;0,05.</p></font>    <p>&nbsp;</p>    ]]></body>
<body><![CDATA[<p><b><font face="Verdana" size="2">RESULTADOS</font></b></p><font face="verdana" size="2">    <p>Foram avaliados 239 doentes. Registou-se um predom&iacute;nio de pacientes do sexo feminino (4:1) e uma m&eacute;dia de idades de 69 anos (43-88). N&atilde;o se encontraram diferen&ccedil;as na lateralidade. A dura&ccedil;&atilde;o m&eacute;dia da cirurgia foi de 92 minutos (39-195). O per&iacute;odo m&iacute;nimo de seguimento foi de 20 meses.</p>
    <p>Identific&aacute;mos 10 doentes com infec&ccedil;&atilde;o profunda (4,18%) e 10 doentes com infec&ccedil;&atilde;o superficial (4,18%).</p>
    <p>Relativamente &agrave;s infecc&otilde;es profundas, encontr&aacute;mos uma rela&ccedil;&atilde;o estatisticamente significativa com a presen&ccedil;a de obesidade (p&lt;0,01), imunodepress&atilde;o (p&lt;0,01) e volume transfusional administrado (p=0,02). Registou-se uma tend&ecirc;ncia para infec&ccedil;&atilde;o profunda, embora sem rela&ccedil;&atilde;o estatisticamente significativa, com maior dura&ccedil;&atilde;o de cirurgia, tempo de administra&ccedil;&atilde;o de antibi&oacute;tico profil&aacute;ctico inferior a 30 minutos antes da incis&atilde;o cir&uacute;rgica, anestesia geral, maiores perdas hem&aacute;ticas, classifica&ccedil;&atilde;o ASA superior, e diabetes mellitus. N&atilde;o se encontrou vantagem de qualquer um dos antibi&oacute;ticos utilizados em rela&ccedil;&atilde;o ao outro na preven&ccedil;&atilde;o de infec&ccedil;&atilde;o profunda.</p></font>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="2">DISCUSSÃO</font></b></p><font face="verdana" size="2">    <p>Este estudo determinou a taxa de infec&ccedil;&atilde;o p&oacute;s artroplastia total do joelho em pacientes consecutivamente operados num hospital central e permite identificar a obesidade, a imunodepress&atilde;o e o volume transfusional administrado como factores de risco significativos para a sua ocorr&ecirc;ncia. Outros factores, habitualmente referidos na literatura, n&atilde;o mostraram associa&ccedil;&atilde;o, ou a tend&ecirc;ncia para infec&ccedil;&atilde;o n&atilde;o atingiu significado estat&iacute;stico.</p>
    <p>Os factores de risco podem ser potencialmente elimin&aacute;veis ou minimiz&aacute;veis, e ligados ao paciente ou extr&iacute;nsecos ao mesmo.</p>
    <p><em>Pulido et al</em> identificaram maior probabilidade de infec&ccedil;&atilde;o periprot&eacute;sica em pacientes com score ASA (American Society of Anesthesiologists) superior a 2[11]. <em>Urquhart et al</em> associam com forte n&iacute;vel de evid&ecirc;ncia infec&ccedil;&atilde;o e pacientes com score ASA &gt; 3[12].</p>
    <p>Um doente diab&eacute;tico possui cerca de 3,1 vezes maior probabilidade de desenvolver infec&ccedil;&atilde;o profunda[13]. Estudos de <em>Marchant et al</em> demonstram franco benef&iacute;cio num controlo estreito das glicemias peroperat&oacute;rias[14]. O bom controlo das glicemias peroperat&oacute;rias observado nos nossos doentes pode explicar a aus&ecirc;ncia de rela&ccedil;&atilde;o com significado estat&iacute;stico encontrada. Os valores de Hemoglobina A1c reflectem o controlo glic&eacute;mico a longo termo e com o apoio da endocrinologia devem ser normalizados previamente &agrave; realiza&ccedil;&atilde;o da artroplastia[15].</p>
    ]]></body>
<body><![CDATA[<p>A obesidade &eacute; um factor de risco transversal na literatura. <em>Malinzak et al</em> reportam uma probabilidade acrescida de 3,3 vezes nos obesos (IMC &gt;40) e encontraram um <em>odds ratio</em> de 21,3 nos obesos com IMC&gt;50[13]. <em>Winiarsky et al</em> compararam um grupo de pacientes com obesidade m&oacute;rbida submetidos a artroplastia total do joelho tendo como controlo grupo n&atilde;o obeso[16]. No grupo com obesidade m&oacute;rbida, 10% dos doentes desenvolveram infec&ccedil;&atilde;o profunda e em 20% dos doentes identificaram-se complica&ccedil;&otilde;es de ferida operat&oacute;ria. Logo &eacute; premente a estimula&ccedil;&atilde;o da diminui&ccedil;&atilde;o do IMC previamente &agrave; artroplastia, tanto atrav&eacute;s de dieta supervisionada por nutricionista ou mesmo por cirurgia bari&aacute;trica (<em>bypass</em> g&aacute;strico)[17].</p>
    <p>Pacientes com doen&ccedil;as inflamat&oacute;rias, anemia falciforme, portadores de HIV, insufici&ecirc;ncia hep&aacute;tica ou renal cr&oacute;nicas t&ecirc;m risco acrescido de infec&ccedil;&atilde;o p&oacute;s artroplastia[15]. A optimiza&ccedil;&atilde;o da reserva fisiol&oacute;gica pr&eacute;-operat&oacute;ria do paciente deve ser m&aacute;xima e dirigida: a carga viral dever&aacute; atingir n&iacute;veis indetect&aacute;veis nos HIV positivos e a hemodi&aacute;lise preconizada nos insuficientes renais cr&oacute;nicos. Pacientes sujeitos a terap&ecirc;utica cr&oacute;nica &agrave; base de corticoester&oacute;ides e imunossupressores (ex. artrite reumat&oacute;ide, status p&oacute;s transplante al&oacute;geno) devem ser consultados previamente &agrave; cirurgia pelo m&eacute;dico assistente de forma a ponderar a redu&ccedil;&atilde;o ou suspens&atilde;o peroperat&oacute;ria da medica&ccedil;&atilde;o inst&iacute;tuida[18].</p>
    <p>A antibioterapia profil&aacute;ctica &eacute; consensualmente eficaz na redu&ccedil;&atilde;o da taxa de infec&ccedil;&atilde;o em artroplastia[17]. <em>Staphylococcus aureus</em> e <em>staphylococcus epidermidis </em>s&atilde;o os respons&aacute;veis pela maioria das infec&ccedil;&otilde;es periprot&eacute;sicas[19]. Estudos recentes demonstram a crescente preval&ecirc;ncia de infec&ccedil;&otilde;es periprot&eacute;sicas causadas por Staphylococcus aureus meticilinoresistentes (MRSA) &ndash; 27% em 1999 para 62% em 2006[<sup>19-21</sup>]. Contudo, no nosso estudo o uso da teicoplanina profil&aacute;ctica <em>vs</em> cefalosporina de primeira gera&ccedil;&atilde;o utilizada (cefazolina) n&atilde;o demonstrou vantagem custo /benef&iacute;cio. A academia americana de cirurgi&otilde;es ortop&eacute;dicos (AAOS) publicou algoritmos para a escolha do antibi&oacute;tico profil&aacute;ctico[<sup>22-24</sup>]. &Eacute; dada prefer&ecirc;ncia &agrave; Cefazolina e Cefuroxima (cefalosporinas de 1&ordf; gera&ccedil;&atilde;o), reservando-se a clindamicina ou vancomicina a pacientes com alergias aos betalact&acirc;micos. A Vancomicina encontra-se igualmente recomendada em pacientes de alto risco para infec&ccedil;&atilde;o por MRSA (institucionalizados, antecedentes de infec&ccedil;&atilde;o documentada por MRSA) ou cuja unidade de cuidados m&eacute;dicos possua na popula&ccedil;&atilde;o de pacientes ortop&eacute;dicos preval&ecirc;ncia superior a 25%.</p>
    <p>Os pacientes colonizados por <em>S. aureus </em>na mucosa nasal tem 2-9 vezes maior probabilidade de desenvolver infec&ccedil;&otilde;es de ferida operat&oacute;ria[25]. Quando a infec&ccedil;&atilde;o ocorre, em 85% dos casos a estirpe isolada na ferida operat&oacute;ria corresponde &agrave; estirpe encontrada na cavidade nasal[25]. Uma das estrat&eacute;gias propostas &eacute; um protocolo de rastreio e descoloniza&ccedil;&atilde;o que pode incluir antibioterapia com vancomicina, mupirocina nasal bidi&aacute;ria e banhos di&aacute;rios de clorohexidina a iniciar 5 dias antes da cirurgia[26]. Um protocolo de descoloniza&ccedil;&atilde;o pr&eacute;operat&oacute;ria pode diminuir o risco de infec&ccedil;&atilde;o dos pacientes colonizados[<sup>27,28</sup>] existindo por&eacute;m estudos contradit&oacute;rios que advertem para a aus&ecirc;ncia de benef&iacute;cio da sua aplica&ccedil;&atilde;o[29]. Logo, n&atilde;o &eacute; presentemente consensual que a aplica&ccedil;&atilde;o de um protocolo de descoloniza&ccedil;&atilde;o a todos os pacientes com indica&ccedil;&atilde;o cir&uacute;rgica seja realisticamente eficaz na redu&ccedil;&atilde;o da taxa de infec&ccedil;&atilde;o em artroplastia[30], aguardando-se estudos cl&iacute;nicos prospectivos randomizados[31]. &Agrave; luz do conhecimento actual, pode ser recomendado que apenas a popula&ccedil;&atilde;o em risco para infec&ccedil;&atilde;o por MRSA seja objecto de rastreio e descoloniza&ccedil;&atilde;o no pr&eacute; operat&oacute;rio. Podemos incluir neste grupo pacientes com infec&ccedil;&atilde;o pr&eacute;via por MRSA ou contactos directos com colonizados, profissionais de sa&uacute;de e institucionalizados (lares 3&ordf; idade, prisioneiros).</p>
    <p>Quanto ao tempo de administra&ccedil;&atilde;o, registamos uma tend&ecirc;ncia para infec&ccedil;&atilde;o profunda nos doentes submetidos a antibioterapia profil&aacute;ctica menos de 30 minutos antes da incis&atilde;o cir&uacute;rgica, embora sem significado estat&iacute;stico. Segundo <em>Bosco et al</em>, a antibioterapia profil&aacute;ctica deve efectuar-se uma hora antes da incis&atilde;o cir&uacute;rgica, previamente &agrave; insufla&ccedil;&atilde;o do garrote15. A excep&ccedil;&atilde;o &eacute; a vancomicina, que deve ser administrada 2 horas antes, o que permite uma infus&atilde;o mais lenta, diminuindo o risco de <em>red man syndrome</em>. Num estudo de Rosenberg et al, a inclus&atilde;o deste passo no <em>&ldquo;time out&rdquo;</em> cir&uacute;rgico aumentou a<em> compliance</em> de 65% para 97%[32].</p>
    <p>A suspens&atilde;o do antibi&oacute;tico deve ser realizada as 24 horas p&oacute;s-operat&oacute;rio. A continua&ccedil;&atilde;o da administra&ccedil;&atilde;o de antibi&oacute;ticos profil&aacute;cticos ap&oacute;s as 24 horas n&atilde;o demonstra efic&aacute;cia e pode conduzir a sobreinfec&ccedil;&atilde;o por microorganismos resistentes[33]. A &ldquo;repicagem&rdquo; peroperat&oacute;ria deve ser realizada em procedimentos cir&uacute;rgicos cuja dura&ccedil;&atilde;o ultrapasse as 4 horas ou quando as perdas sangu&iacute;neas excedam 1500ml.</p>
    <p>Apesar de tempos cir&uacute;rgicos mais prolongados poderem corresponder a procedimentos igualmente mais complexos a sua redu&ccedil;&atilde;o deve ser adere&ccedil;ada, dada a evid&ecirc;ncia como factor de risco independente para infec&ccedil;&atilde;o[<sup>34-35</sup>]. De referir que os estudos que apoiam esta associa&ccedil;&atilde;o comparam 2 grupos de doentes cuja dura&ccedil;&atilde;o de procedimento tenha sido superior a 210 minutos ou inferior a 120 minutos, o que traduzem valores de &ldquo;<em>cut off</em>&rdquo; elevados n&atilde;o aplic&aacute;veis na nossa pr&aacute;tica cl&iacute;nica, j&aacute; que no nosso estudo registamos tempos operat&oacute;rios m&eacute;dios de 92 minutos e da&iacute; possivelmente resultar&aacute; a aus&ecirc;ncia encontrada de rela&ccedil;&atilde;o com significado estat&iacute;stico.</p>
    <p>A anestesia do neuroeixo tem sido favorecida em procedimentos de artroplastia do membro inferior. A anestesia locoregional do neuroeixo pelo seu efeito hipotensor, diminui as perdas hem&aacute;ticas e pelas propriedades vasodilatadoras, o risco de eventos tromboemb&oacute;licos. Diminui igualmente a necessidade de analgesia endovenosa[36].</p>
    <p>A morfina inibe a ac&ccedil;&atilde;o bactericida dos neutr&oacute;filos, logo o seu menor consumo no p&oacute;s operat&oacute;rio imediato pode estar associada &agrave; diminui&ccedil;&atilde;o do risco de infec&ccedil;&atilde;o em fase aguda[36].</p>
    <p>Tem sido relatada evid&ecirc;ncia crescente de que a administra&ccedil;&atilde;o de hemoderivados confere maior risco de infec&ccedil;&atilde;o periprot&eacute;sica. <em>Pulido et al</em> demonstraram que doentes que recebam transfus&atilde;o p&oacute;s operat&oacute;ria de gl&oacute;bulos rubros (GR) possuem 2,1 vezes maior probabilidade de contrair infec&ccedil;&atilde;o periprot&eacute;sica[11]. Esta associa&ccedil;&atilde;o encontra fundamento na imunomodula&ccedil;&atilde;o provocada pela administra&ccedil;&atilde;o de sangue alog&eacute;nico e pela les&atilde;o de armazenamento dos GR e sua ac&ccedil;&atilde;o inibit&oacute;ria sobre a microcircula&ccedil;&atilde;o e o aporte de oxig&eacute;nio ao local operat&oacute;rio. A autotransfus&atilde;o adivinha-se uma alternativa v&aacute;lida[37]. Defendemos a realiza&ccedil;&atilde;o de hemostase peroperat&oacute;ria cuidada e transfus&atilde;o criteriosa: anemia sintom&aacute;tica (taquicardia, taquipneia, hipotens&atilde;o) ou Hemoglobina &lt;8g/dl ou &lt;9g/dl de forma a n&atilde;o causar agravamento de comorbilidades (Insufici&ecirc;ncia card&iacute;aca congestiva, arritmias, entre outros)[37].</p>
    ]]></body>
<body><![CDATA[<p>Face &agrave; taxa de infec&ccedil;&atilde;o identificada, foram j&aacute; adoptadas medidas de controlo adicionais e sistem&aacute;ticas, tendo por objectivo a sua redu&ccedil;&atilde;o.</p>
    <p>Consistiram na identifica&ccedil;&atilde;o pr&eacute;via dos doentes de risco; no estabelecimento efectivo de um protocolo de antibioterapia profil&aacute;ctica (administra&ccedil;&atilde;o 1h antes da incis&atilde;o cir&uacute;rgica), apenas poss&iacute;vel devido a estreita coordena&ccedil;&atilde;o entre a equipa de enfermagem do internamento e a do bloco operat&oacute;rio; modifica&ccedil;&otilde;es na prepara&ccedil;&atilde;o do campo operat&oacute;rio, incluindo o banho pr&eacute;vio com clorexidina, tricotomia n&atilde;o abrasiva e desinfec&ccedil;&atilde;o do membro inferior com clorexidina alco&oacute;lica; adop&ccedil;&atilde;o exclusiva de solu&ccedil;&atilde;o alco&oacute;lica para desinfec&ccedil;&atilde;o das m&atilde;os da equipa cir&uacute;rgica; uso de luvas cir&uacute;rgicas sem p&oacute; (2 pares) e, por &uacute;ltimo, controlo efectivo do tr&acirc;nsito da sala operat&oacute;ria, tendo em considera&ccedil;&atilde;o as limita&ccedil;&otilde;es inerentes a um hospital central, universit&aacute;rio e escolar, com obriga&ccedil;&otilde;es formativas pr&eacute; e p&oacute;s graduadas.</p>
    <p>As referidas estrat&eacute;gias de preven&ccedil;&atilde;o aplicadas ser&atilde;o objecto de estudo posterior para avalia&ccedil;&atilde;o da sua efic&aacute;cia.</p></font>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="2">CONCLUSÃO</font></b></p><font face="verdana" size="2">    <p>A infec&ccedil;&atilde;o em artroplastia acarreta elevado impacto socioecon&oacute;mico, tanto pelos custos directos, atribu&iacute;dos &agrave;s interven&ccedil;&otilde;es, implantes e dias de internamento como pelos custos indirectos, nos danos psicol&oacute;gicos, profissionais e sobre as actividades do quotidiano.</p>
    <p>A incid&ecirc;ncia de infec&ccedil;&atilde;o p&oacute;s artroplastia total do joelho em pacientes consecutivamente operados num hospital central foi elevada (4,18% infec&ccedil;&otilde;es profundas e 4,18% infec&ccedil;&otilde;es superficiais).</p>
    <p>A obesidade, a imunodepress&atilde;o e o volume transfusional administrado foram factores de risco significativos para a ocorr&ecirc;ncia de infec&ccedil;&atilde;o. Outros factores, habitualmente referidos na literatura, n&atilde;o mostraram associa&ccedil;&atilde;o ou a tend&ecirc;ncia para infec&ccedil;&atilde;o n&atilde;o atingiu significado estat&iacute;stico.</p>
    <p>&Eacute;, portanto, mandat&oacute;rio identificar os factores de risco, corrigi-los ou control&aacute;-los de forma a prevenir infec&ccedil;&atilde;o.</p></font>    <p>&nbsp;</p>    ]]></body>
<body><![CDATA[<p><b><font face="Verdana" size="2">REFERÊNCIAS BIBLIOGRÁFICAS</font></b></p>    <p><font face="verdana" size="2">1. Parvizi J, Tarity TD, Steinbeck MJ, Politi RG, Joshi A, Purtill JJ, et al. Management of Stiffness Following Total Knee Arthroplasty. J Bone Joint Surg. 2006; 88 (4): 138-147</font></p>    <!-- ref --><p><font face="verdana" size="2">2. Herberts P, Malchau H. A review of the Swedish THR Register comparing 160,000 cases. Acta Orthop Scand. 2000; 71: 111-121</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000075&pid=S1646-2122201200040000500002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">3. Sharkey P. F., Hozack W. J., Rothman R. H., Shastri S., Jacoby S. M.. Insall Award paper. Why are total knee arthroplasties failing today?. Clin Orthop Relat Res. 2002; 404: 7-13</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000076&pid=S1646-2122201200040000500003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">4. Duff GP, Lachiewicz PF, Kelley SS. Aspiration of the knee joint before revision arthroplasty. Clin Orthop Relat Res. 1996; 331: 132-139</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000077&pid=S1646-2122201200040000500004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">5. Peersman G, Laskin R, Davis J, Petterson M. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res. 2001; 392: 15-23</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000078&pid=S1646-2122201200040000500005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">6. Powers KA, Terpenning MS, Voice RA, Kauffman CA. Prosthetic joint infections in the erderly. AM J Med. 1990; 88: 9-13</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000079&pid=S1646-2122201200040000500006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">7. Berbari EF, Hanssen AD, Duffy MC. Risk factors for prosthetic joint infection: casecontrol study. Clin Infect Dis. 1998; 27 (5): 1247-1254</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000080&pid=S1646-2122201200040000500007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">8. Kurtz S, Ong K, Lau E. Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007; 89 (4): 780-785</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000081&pid=S1646-2122201200040000500008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">9. Kurtz SM, Lau E, Schmier J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008; 23 (7): 984-991</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000082&pid=S1646-2122201200040000500009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">10. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC Definitions of Nosocomial Surgical Site Infections, 1992: A Modification of CDC Definitions of Surgical Wound Infections. Infect Control Hosp Epidemiol. 1992; 13: 606-608</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000083&pid=S1646-2122201200040000500010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">11. Pulido L. Periprosthetic joint infection: the incidence, timing and predisposing factors. Clin Ortho Relat Res. 2008; 466: 1710-1725</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000084&pid=S1646-2122201200040000500011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">12. Urquhart DM.  Incidence and risk factors for deep surgical site infection after primary arthroplasty: a systematic review. J Arthroplasty. 2009; 25 (8): 1216-1222</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000085&pid=S1646-2122201200040000500012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">13. Malinzak RA, Ritter MA, Berend ME, Meding JB, Olberding EM, Davis KE. Morbidly obese, diabetic,younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty. 2009; 24: 84-88</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000086&pid=S1646-2122201200040000500013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">14. Marchant Jr. MH, Viens NA, Cook C, Vail TP, Bolognesi MP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009; 91: 1621-1629</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000087&pid=S1646-2122201200040000500014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">15. Bosco III J. Perioperative strategies for decreasing infection. J Bone Joint Surg Am. 2010; 92: 232-239</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000088&pid=S1646-2122201200040000500015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">16. Winiarsky R, Barth P, Lotke P. Total knee arthroplasty in morbidly obese patients. J Bone Joint Surg Am. 1998; 80: 1770-1774</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000089&pid=S1646-2122201200040000500016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">17. Garvin KL, Konigsberg BS. Infection Following Total Knee Arthroplasty: Prevention and Management. J Bone Joint Surg Am. 2011; 93 (12): 1167-1175</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000090&pid=S1646-2122201200040000500017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">18. Wicke C, Halliday B, Allen D.  Effects of steroids and retinoids on wound healing. Arch Surg. 2000; 135 (11): 1265-1270</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000091&pid=S1646-2122201200040000500018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">19. Parvizi J, Bender B, Saleh KJ, Brown TE, Schmalzried TP, Mihalko WM. Resistant organisms in infected total knee arthroplasty: Occurance, prevention, and treatment regimens. Instr Course Lect 15. 2009; 58: 271-278</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000092&pid=S1646-2122201200040000500019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">20. Ip D, Yam SK, Chen CK. Implications of the changing pattern of bacterial infections following total joint replacement. J Orthop Surg (Hong Kong). 2005; 13: 125-130</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000093&pid=S1646-2122201200040000500020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p><font face="verdana" size="2">21. Fulkerson E, Valle CJ, Wise B, Walsh M, Preston C, Di Cesare PE. Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am. 2006; 88: 1231-1237</font></p>    <!-- ref --><p><font face="verdana" size="2">22. Recommendations for the use of intravenous antibiotic prophylaxis in primary total joint arthroplasty. American Academy of Orthopaedic Surgeons; 2004.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000095&pid=S1646-2122201200040000500022&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --> </font></p>    <!-- ref --><p><font face="verdana" size="2">23. The use of prophylactic antibiotics in orthopaedic medicine and the emergence of vancomycin-resistant bacteria. American Academy of Orthopaedic Surgeons; 1998.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000097&pid=S1646-2122201200040000500023&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --> </font></p>    <p><font face="verdana" size="2">24. Finkelstein R, Rabino G, Mashiah T, Bar-El Y, Adler Z, Kertzman V, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg. 2002; 123: 326-332</font></p>    <!-- ref --><p><font face="verdana" size="2">25. Wenzel RP, Perl TM. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect. 1995; 31: 13-24</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000100&pid=S1646-2122201200040000500025&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">26. Rao N, Cannella B, Crossett LS, Yates AJ Jr, McGough R 3rd. A preoperative decolonization protocol for staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res. 2008; 466: 1343-1348</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000101&pid=S1646-2122201200040000500026&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">27. van Rijen M, Bonten M, Wenzel R, Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev. 2008; 4</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000102&pid=S1646-2122201200040000500027&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">28. van Rijen MM, Kluytmans JA. New approaches to prevention of staphylococcal infection in surgery. Curr Opin Infect Dis. 2008; 21: 380-384</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000103&pid=S1646-2122201200040000500028&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p><font face="verdana" size="2">29. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, Bogaers-Hofman D, de Baere GA, Stuurman A, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind,randomized, placebo-controlled study. Clin Infect Dis. 2002; 35: 353-358</font></p>    <!-- ref --><p><font face="verdana" size="2">30. Trautmann M, Stecher J, Hemmer W, Luz K, Panknin HT. Intranasal mupirocin prophylaxis in elective surgery. A review of published studies. Chemotherapy. 2008; 54: 9-16</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000105&pid=S1646-2122201200040000500030&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">31. Parvizi J, Matar WY, Saleh HJ, Schmalzried TP, Mihalko WM. Decolonization of drugresistant organisms before total joint arthroplasty. Instr Course Lect. 2010; 59: 131-137</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000106&pid=S1646-2122201200040000500031&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p><font face="verdana" size="2">32. Rosenberg AD, Wambold D, Kraemer L, Begley-Keyes M, Zuckerman SL, Singh N, et al. Ensuring appropriate timing of antimicrobial prophylaxis. J Bone Joint Surg Am. 2008; 90: 226-232</font></p>    <!-- ref --><p><font face="verdana" size="2">33. Slobogean GP, Kennedy SA, Davidson D, O’Brien PJ. Single- versus multiple-dose antibiotic prophylaxis in the surgical treatment of closed fractures: a meta-analysis. J Orthop Trauma. 2008; 22: 264-269</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000108&pid=S1646-2122201200040000500033&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">34. Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J.  Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010; 468: 52-56</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000109&pid=S1646-2122201200040000500034&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">35. Huotari K, Agthe N, Lyytikinen O. Validation of surgical site infection surveillance in orthopedic procedures. Am J Infect Control. 2007; 35: 216-221</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000110&pid=S1646-2122201200040000500035&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">36. Victor Jan, Bellemans Johan, Ries Michael D., Victor  Jan M.K.. Total Knee Arthroplasty. 1st. Germany: Springer; 2005.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000111&pid=S1646-2122201200040000500036&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --> </font></p>    ]]></body>
<body><![CDATA[<p><font face="verdana" size="2">37. Matar WY, Jafari SM, Restrepo C, Austin M, Purtill JJ, Parvizi J. Preventing infection in total joint arthroplasty. J Bone Joint Surg Am. 2010 Dec; 92 (2): 36-46</font></p>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="2">Conflito de interesse: </font></b></p><font face="verdana" size="2">    <p>Nada a declarar.</p></font>    <p>&nbsp;</p><a name="c"></a>    <p><b><font face="Verdana" size="2"><a href="#topc">Endereço para correspondência</a></font></b></p>    <p><font face="Verdana" size="2">Pedro Rodrigues    <br>Serviço de Ortopedia e Traumatologia    <br>Centro Hospitalar São João    <br>Faculdade de Medicina da Universidade do Porto    ]]></body>
<body><![CDATA[<br>Al. Prof. Hernâni Monteiro     <br>4200 Porto    <br>Portugal    <br><a href="mailto:pedrocachorodrigues@gmail.com">pedrocachorodrigues@gmail.com</a>    <br></font></p>    <p>&nbsp;</p>    <p><font face="verdana" size="2"><b>Data de Submissão: </b> 2012-07-02</font></p>    <p><font face="verdana" size="2"><b>Data de Revisão: </b> 2012-10-28</font></p>    <p><font face="verdana" size="2"><b>Data de Aceitação: </b> 2012-10-31</font></p>     ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parvizi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tarity]]></surname>
<given-names><![CDATA[TD]]></given-names>
</name>
<name>
<surname><![CDATA[Steinbeck]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Politi]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Joshi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Purtill]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sharkey]]></surname>
<given-names><![CDATA[PF]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Management of Stiffness Following Total Knee Arthroplasty]]></article-title>
<source><![CDATA[J Bone Joint Surg]]></source>
<year>2006</year>
<volume>88</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>138-147</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herberts]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Malchau]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A review of the Swedish THR Register comparing 160,000 cases]]></article-title>
<source><![CDATA[Acta Orthop Scand]]></source>
<year>2000</year>
<volume>71</volume>
<page-range>111-121</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sharkey]]></surname>
<given-names><![CDATA[P. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Hozack]]></surname>
<given-names><![CDATA[W. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Rothman]]></surname>
<given-names><![CDATA[R. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Shastri]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Jacoby]]></surname>
<given-names><![CDATA[S. M.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Insall Award paper. Why are total knee arthroplasties failing today?]]></article-title>
<source><![CDATA[Clin Orthop Relat Res]]></source>
<year>2002</year>
<volume>404</volume>
<page-range>7-13</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duff]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[Lachiewicz]]></surname>
<given-names><![CDATA[PF]]></given-names>
</name>
<name>
<surname><![CDATA[Kelley]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Aspiration of the knee joint before revision arthroplasty]]></article-title>
<source><![CDATA[Clin Orthop Relat Res]]></source>
<year>1996</year>
<volume>331</volume>
<page-range>132-139</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peersman]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Laskin]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Petterson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Infection in total knee replacement: a retrospective review of 6489 total knee replacements]]></article-title>
<source><![CDATA[Clin Orthop Relat Res]]></source>
<year>2001</year>
<volume>392</volume>
<page-range>15-23</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Powers]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Terpenning]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Voice]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Kauffman]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prosthetic joint infections in the erderly]]></article-title>
<source><![CDATA[AM J Med]]></source>
<year>1990</year>
<volume>88</volume>
<page-range>9-13</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berbari]]></surname>
<given-names><![CDATA[EF]]></given-names>
</name>
<name>
<surname><![CDATA[Hanssen]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Duffy]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Risk factors for prosthetic joint infection: casecontrol study]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>1998</year>
<volume>27</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1247-1254</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kurtz]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ong]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Lau]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030]]></article-title>
<source><![CDATA[J Bone Joint Surg Am]]></source>
<year>2007</year>
<volume>89</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>780-785</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kurtz]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Lau]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Schmier]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Infection burden for hip and knee arthroplasty in the United States]]></article-title>
<source><![CDATA[J Arthroplasty]]></source>
<year>2008</year>
<volume>23</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>984-991</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Horan]]></surname>
<given-names><![CDATA[TC]]></given-names>
</name>
<name>
<surname><![CDATA[Gaynes]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Martone]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Jarvis]]></surname>
<given-names><![CDATA[WR]]></given-names>
</name>
<name>
<surname><![CDATA[Emori]]></surname>
<given-names><![CDATA[TG]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[CDC Definitions of Nosocomial Surgical Site Infections, 1992 A Modification of CDC Definitions of Surgical Wound Infections]]></article-title>
<source><![CDATA[Infect Control Hosp Epidemiol]]></source>
<year>1992</year>
<volume>13</volume>
<page-range>606-608</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pulido]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Periprosthetic joint infection: the incidence timing and predisposing factors]]></article-title>
<source><![CDATA[Clin Ortho Relat Res]]></source>
<year>2008</year>
<volume>466</volume>
<page-range>1710-1725</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Urquhart]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Incidence and risk factors for deep surgical site infection after primary arthroplasty: a systematic review]]></article-title>
<source><![CDATA[J Arthroplasty]]></source>
<year>2009</year>
<volume>25</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1216-1222</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malinzak]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Ritter]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Berend]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Meding]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Olberding]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[KE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Morbidly obese, diabetic,younger and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates]]></article-title>
<source><![CDATA[J Arthroplasty]]></source>
<year>2009</year>
<volume>24</volume>
<page-range>84-88</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marchant]]></surname>
<given-names><![CDATA[Jr. MH]]></given-names>
</name>
<name>
<surname><![CDATA[Viens]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Cook]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Vail]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[Bolognesi]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty]]></article-title>
<source><![CDATA[J Bone Joint Surg Am]]></source>
<year>2009</year>
<volume>91</volume>
<page-range>1621-1629</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bosco III]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Perioperative strategies for decreasing infection]]></article-title>
<source><![CDATA[J Bone Joint Surg Am]]></source>
<year>2010</year>
<volume>92</volume>
<page-range>232-239</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Winiarsky]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Barth]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lotke]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Total knee arthroplasty in morbidly obese patients]]></article-title>
<source><![CDATA[J Bone Joint Surg Am]]></source>
<year>1998</year>
<volume>80</volume>
<page-range>1770-1774</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garvin]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Konigsberg]]></surname>
<given-names><![CDATA[BS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Infection Following Total Knee Arthroplasty: Prevention and Management]]></article-title>
<source><![CDATA[J Bone Joint Surg Am]]></source>
<year>2011</year>
<volume>93</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1167-1175</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wicke]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Halliday]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Allen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Effects of steroids and retinoids on wound healing]]></article-title>
<source><![CDATA[Arch Surg]]></source>
<year>2000</year>
<volume>135</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1265-1270</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parvizi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bender]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Saleh]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
<name>
<surname><![CDATA[Schmalzried]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[Mihalko]]></surname>
<given-names><![CDATA[WM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Resistant organisms in infected total knee arthroplasty: Occurance prevention and treatment regimens]]></article-title>
<source><![CDATA[Instr Course Lect 15]]></source>
<year>2009</year>
<volume>58</volume>
<page-range>271-278</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ip]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Yam]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Implications of the changing pattern of bacterial infections following total joint replacement]]></article-title>
<source><![CDATA[J Orthop Surg (Hong Kong)]]></source>
<year>2005</year>
<volume>13</volume>
<page-range>125-130</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fulkerson]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Valle]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Wise]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Preston]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cesare]]></surname>
<given-names><![CDATA[PE Di]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites]]></article-title>
<source><![CDATA[J Bone Joint Surg Am]]></source>
<year>2006</year>
<volume>88</volume>
<page-range>1231-1237</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<article-title xml:lang="en"><![CDATA[Recommendations for the use of intravenous antibiotic prophylaxis in primary total joint arthroplasty]]></article-title>
<collab>American Academy of Orthopaedic Surgeons</collab>
<source><![CDATA[]]></source>
<year>2004</year>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="">
<article-title xml:lang="en"><![CDATA[The use of prophylactic antibiotics in orthopaedic medicine and the emergence of vancomycin-resistant bacteria]]></article-title>
<collab>American Academy of Orthopaedic Surgeons</collab>
<source><![CDATA[]]></source>
<year>1998</year>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Finkelstein]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rabino]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Mashiah]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Bar-El]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Adler]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Kertzman]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Milo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections]]></article-title>
<source><![CDATA[J Thorac Cardiovasc Surg]]></source>
<year>2002</year>
<volume>123</volume>
<page-range>326-332</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wenzel]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Perl]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection]]></article-title>
<source><![CDATA[J Hosp Infect]]></source>
<year>1995</year>
<volume>31</volume>
<page-range>13-24</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rao]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Cannella]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Crossett]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Yates]]></surname>
<given-names><![CDATA[AJ Jr]]></given-names>
</name>
<name>
<surname><![CDATA[McGough]]></surname>
<given-names><![CDATA[R 3rd]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A preoperative decolonization protocol for staphylococcus aureus prevents orthopaedic infections]]></article-title>
<source><![CDATA[Clin Orthop Relat Res]]></source>
<year>2008</year>
<volume>466</volume>
<page-range>1343-1348</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[van Rijen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bonten]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wenzel]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kluytmans]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2008</year>
<volume>4</volume>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[van Rijen]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Kluytmans]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[New approaches to prevention of staphylococcal infection in surgery]]></article-title>
<source><![CDATA[Curr Opin Infect Dis]]></source>
<year>2008</year>
<volume>21</volume>
<page-range>380-384</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalmeijer]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Coertjens]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[van Nieuwland-Bollen]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Bogaers-Hofman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Baere]]></surname>
<given-names><![CDATA[GA de]]></given-names>
</name>
<name>
<surname><![CDATA[Stuurman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[van Belkum]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kluytmans]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind,randomized placebo-controlled study]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2002</year>
<volume>35</volume>
<page-range>353-358</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Trautmann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Stecher]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hemmer]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Luz]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Panknin]]></surname>
<given-names><![CDATA[HT]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Intranasal mupirocin prophylaxis in elective surgery: A review of published studies]]></article-title>
<source><![CDATA[Chemotherapy]]></source>
<year>2008</year>
<volume>54</volume>
<page-range>9-16</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parvizi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Matar]]></surname>
<given-names><![CDATA[WY]]></given-names>
</name>
<name>
<surname><![CDATA[Saleh]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
<name>
<surname><![CDATA[Schmalzried]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[Mihalko]]></surname>
<given-names><![CDATA[WM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Decolonization of drugresistant organisms before total joint arthroplasty]]></article-title>
<source><![CDATA[Instr Course Lect]]></source>
<year>2010</year>
<volume>59</volume>
<page-range>131-137</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosenberg]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Wambold]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kraemer]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Begley-Keyes]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zuckerman]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Ensuring appropriate timing of antimicrobial prophylaxis]]></article-title>
<source><![CDATA[J Bone Joint Surg Am]]></source>
<year>2008</year>
<volume>90</volume>
<page-range>226-232</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Slobogean]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Davidson]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[O’Brien]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Single: versus multiple-dose antibiotic prophylaxis in the surgical treatment of closed fractures a meta-analysis]]></article-title>
<source><![CDATA[J Orthop Trauma]]></source>
<year>2008</year>
<volume>22</volume>
<page-range>264-269</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kurtz]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Ong]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Lau]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bozic]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Berry]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Parvizi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prosthetic joint infection risk after TKA in the Medicare population]]></article-title>
<source><![CDATA[Clin Orthop Relat Res]]></source>
<year>2010</year>
<volume>468</volume>
<page-range>52-56</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huotari]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Agthe]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Lyytikinen]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Validation of surgical site infection surveillance in orthopedic procedures]]></article-title>
<source><![CDATA[Am J Infect Control]]></source>
<year>2007</year>
<volume>35</volume>
<page-range>216-221</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Victor]]></surname>
<given-names><![CDATA[Jan]]></given-names>
</name>
<name>
<surname><![CDATA[Bellemans]]></surname>
<given-names><![CDATA[Johan]]></given-names>
</name>
<name>
<surname><![CDATA[Ries]]></surname>
<given-names><![CDATA[Michael D.]]></given-names>
</name>
<name>
<surname><![CDATA[Victor]]></surname>
<given-names><![CDATA[Jan M.K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Total Knee Arthroplasty]]></source>
<year>2005</year>
<edition>1st</edition>
<publisher-loc><![CDATA[Germany ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Matar]]></surname>
<given-names><![CDATA[WY]]></given-names>
</name>
<name>
<surname><![CDATA[Jafari]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Restrepo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Austin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Purtill]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Parvizi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Preventing infection in total joint arthroplasty]]></article-title>
<source><![CDATA[J Bone Joint Surg Am]]></source>
<year>12/2</year>
<month>01</month>
<day>0</day>
<volume>92</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>36-46</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
